T45 Labs ยท 1 month ago
Senior Clinical Research Associate - VahatiCor
T45 Labs is a medical device company focused on developing breakthrough cardiovascular technologies. The Senior Clinical Research Associate will provide advanced monitoring oversight, site engagement, documentation review, and inspection-readiness support across all phases of cardiovascular clinical studies.
ManufacturingMedicalMedical Device
Responsibilities
Lead monitoring activities to ensure compliance with protocols, SOPs, FDA regulations, and ICH/GCP guidelines
Conduct qualification, initiation, interim, and close-out visits (in-person and remote)
Perform source data verification, eCRF review, and oversee query resolution
Maintain strong relationships with investigational sites to support enrollment, data quality, and overall study performance
Provide timely issue identification, escalation, and follow-up
Review and support development of study materials such as monitoring plans, site tools, and trackers
Ensure TMF quality, accuracy, and completeness
Contribute to vendor oversight activities and quality checks
Support audit and inspection-readiness processes
Work closely with CTMs, data management, clinical leadership, and vendors
Support investigational product tracking and reconciliation
Participate in study team meetings and provide operational insight
Qualification
Required
Bachelor's degree in the life sciences or a related field
Minimum 5+ years of experience as a CRA, with significant experience in medtech; cardiovascular device experience strongly preferred
Demonstrated success monitoring early-stage and/or Class III device trials
Strong knowledge of FDA regulations, ICH/GCP, and clinical research operations
Excellent communication, site management, and documentation skills
Ability to travel up to approximately 50%
Comfortable working in a dynamic, fast-paced environment
Preferred
Cardiovascular device experience strongly preferred
Benefits
Bonuses
Equity
Benefits
Company
T45 Labs
T45 Labs is a med-tech incubator that specializes in developing minimally invasive technologies for the cardiovascular market.
Funding
Current Stage
Early StageRecent News
Venture Capital
2025-11-19
Company data provided by crunchbase